BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Chronic Fatigue Syndrome Therapeutics Market: Rise in awareness about chronic fatigue syndrome and treatment is expected to drive the market

  Chronic fatigue syndrome, also known as Myalgic encephalomyelitis, is a chronic disease which lasts for six months and affects the central nervous system and the immune system.

  February 24, 2022

   · 

  7 min read
• The Global Medical Membranes Market is Anticipated to Top A Valuation Of US$ 3 Bn By 2031

  The Fact.MR market study on the medical membrane market provides deep dive into key developments in the medical membrane market.

  February 24, 2022

   · 

  6 min read
• Veterinary Pain Management Market Outlook 2026

  Rapid advances in the global veterinary pain management market stem from the momentum gained from rising awareness about pain management in companion animals, especially cats and dogs.

  February 24, 2022

   · 

  5 min read
• Business

  Calliditas Therapeutics Year-End Report, 2021

  The accelerated approval of TARPEYO was for the indication of reduction of proteinuria, which was the endpoint of Part A of the trial, in adult patients with IgA nephropathy with risk of rapid progression, which is characterized as generally UPCR ≥ 1.5 g/g.

  February 24, 2022

   · 

  6 min read
• Connected pen injector add-on designed by SHL Medical wins 2021 Good Design Award

  SHL Medical and Innovation Zed is pleased to share the news that Innovation Zed’s injection time-tracker connected device, the InsulCheck CONNECT, a device that was designed by SHL Medical, has been selected as a winner of the 2021 Good Design Award.

  February 24, 2022

   · 

  3 min read
• Orexo’s lead product ZUBSOLV® added to NY State Medicaid MAT Preferred Drug List

  Orexo AB, announced information about improved market access position for ZUBSOLV® sublingual tablet for opioid dependence.

  February 24, 2022

   · 

  3 min read
• Business

  Genus plc Reports Interim Results for the Six Months Ended 31 December 2021

  Genus, a leading global animal genetics company, announces its interim results for the six months ended 31 December 2021.

  February 24, 2022

   · 

  11 min read
• GliaPharm SA and the Wyss Center Enter Collaboration to Develop New Therapies for Alzheimer’s Disease

  GliaPharm SA and the Wyss Center announced a collaboration to develop new treatments for Alzheimer’s disease.

  February 24, 2022

   · 

  3 min read
• Business

  Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results

  Nautilus Biotechnology, Inc., a company pioneering a single molecule proteome analysis platform, reported financial results for the fourth quarter and fiscal year ended December 31, 2021.

  February 24, 2022

   · 

  9 min read
• Biotech Bay

  Endpoint Health Enters into Global Collaboration and Licensing Agreement with Grifols

  Endpoint Health, Inc. announced that the company has entered into a global collaboration and licensing agreement with Grifols, a leading global producer of plasma-derived medicines, under which Endpoint Health will receive exclusive rights to develop and commercialize Antithrombin III in sepsis.

  February 24, 2022

   · 

  5 min read